CoP Session: Biotechnology
10:00 AM – 10:45 AM | Red Level Press Box
TRANSFORMATION WITH INTENTION: How can I get more involved?
With over 6.1K subscribers, the ISPE Biotech Community of Practice (CoP) is the very heartbeat and cornerstone of the life sciences industry in bringing relevant, trending and helpful content to our thriving community.
Come join us on this interactive roadmap overview of this very active CoP to see how our leaders are contributing and staying engaged. The Biotech CoP is proud to be the sponsor of many ISPE Guidance Documents including the recently published ISPE Baseline Guide Volume 6, 3rd Edition : Biopharmaceutical Manufacturing Facilities that has received global recognition. Join us to see how you can play your part in contributing and staying intentionally engaged with this dynamic CoP. We develop content FOR experts BY experts.
Speakers:
Laura-Ann Chin, Director, Life Sciences, BW Design Group
Amit Kumar, PhD, Small & Large Molecules Site Lead, Moderna
Biographies:
Laura-Ann Chin, Director, Life Sciences, BW Design Group
Laura-Ann Chin brings over 13 years of international and domestic contract and hands on process engineering experience in the design and construction of cGMP facilities in the US, Europe and Asia. She currently leads as the 2025 ISPE Delaware Valley Chapter President.
Laura-Ann’s role as Director of Life Sciences with Barry-Wehmiller Design Group allows her the opportunity to cross-link years of authentic relationship building coupled with people-centric leadership and technical knowledge to bring cutting-edge, bespoke and compelling solutions to the Life Sciences & Biotech community and beyond.
She specializes in Single-Use Solutions and Modular Technologies for Scale-Up, Scale-Out and Technology Transfer of ATMP, biotech, and bulk pharmaceutical facilities.
Laura-Ann’s dynamic proficiency in process engineering combines best business practices and technical expertise in executing projects with exceptional value, speed and compliance. She prides herself in engaging clients upfront and developing strong relationships in the design process.
In most recent years, Laura-Ann has taken a strong affinity in the development of Advanced Therapy Medicinal Products (ATMP) Clinical and Commercial Manufacturing facilities where she continues to extend value and creative solutions to cutting-edge clients.
Laura-Ann serves an active role on the executive board of ISPE Delaware Valley Chapter (DVC), ISPE Biotechnology Communities of Practice (COP) Co-Chair, ISPE Biotechnology Conference Programming Committee and is a sounding director on the AIChE DVS Board.
In 2015, Laura-Ann was named Young Chemical Engineer of the Year by the American Institute of Chemical Engineers Delaware Valley Section.
Amit Kumar, PhD, Small & Large Molecules Site Lead, Moderna
Dr. Amit Kumar has many years of experience spanning industry, academia, and global biopharmaceuticals. Currently serving as global process and technology lead for small and large molecules at Moderna Therapeutics, Dr. Kumar leads strategic initiatives across mRNA, DNA, and protein platforms.
Prior to Moderna, he held roles at Amgen, the Massachusetts Institute of Technology (MIT), contributing to the optimization of commercial manufacturing technologies, process modeling, and innovation in biologics and small molecule production.
He holds a Ph.D. in Bioscience Engineering specializing in biochemical process from Ghent University, with collaborative research conducted across UMass Amherst, TU Delft, and TU Munich. He completed postdoctoral training at MIT and Harvard University, specializing in process science and technology. A recipient of more than 25 national and international awards, including the prestigious Marie Curie Fellowship, He is an active contributor to the field through roles on editorial boards, industry ISPE working groups including the community of Biotechnology Practice, and scientific committees.
